 Progress cardioprotection role calcium antagonists Calcium antagonists treatment clinical hypertension angina pectoris efficacious treatment vasospastic atherosclerotic mixed angina incidence silent ischemia postmyocardial infarct angina Experimental data suggest certain cardioprotective properties cases acute myocardial ischemia infarction myocardium diastolic dysfunction ventricular hypertrophy atherosclerosis exercise performance diastolic abnormalities patients hypertrophic cardiomyopathy animals extent myocardial necrosis coronary occlusion coronary occlusion reperfusion low doses hemodynamic profile return ventricular function animals stunned myocardium early first-generation calcium antagonists nifedipine verapamil diltiazem myocardial infarct size survival patients acute myocardial infarction clinical studies beta blockers nitrates nifedipine development atherosclerotic progression humans period likely expansion use calcium antagonists hypertension aspects cardioprotection calcium antagonists prevent regress atherosclerotic lesions exciting possibility